Evidence map›Paper›PMID 42109680›Full record

ArticleFrontiers in oncology2026

Correction: A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion.

Dhabya Majid, Zhe Wang, Amanda M Schalk, Bin Yuan, Qi Zhang Tatarata, Jessica L Root, Araceli Isabella Garza, Mhd Yousuf Yassouf, Basant T Gamal, Sammy Feri-Borgogno and 8 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Dhabya Majid *Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Zhe Wang *Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Amanda M SchalkDepartment of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States.
Bin YuanDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Qi Zhang TatarataDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Jessica L RootDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Araceli Isabella GarzaDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Mhd Yousuf YassoufDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Basant T GamalDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Sammy Feri-BorgognoDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Annie Hoai NguyenDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Marina KonoplevaDepartment of Oncology, Montefiore Einstein, Bronx, NY, United States.
Evelien PeetersDepartment of Diagnostic Sciences, Ghent University, Ghent, Belgium.
Ying SuDepartment of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States.
Patrick K RevilleDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Farhad Ravandi-KashaniDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Arnon LavieDepartment of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, IL, United States.
Hussein A AbbasDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2025.1606239.].

Indexed as

acute myeliod leukemiaAMLAML with deletion 7asparaginasecombination treatmentleukemiavenetoclax

Identifiers

PMID42109680
PMCPMC13150448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.